- Exchange: ASE
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Agricultural Biotech
Trading has been suspended for STI:AU
Snapshot for Stirling Products Ltd (STI)
| Open: | - | Day's Range: | - | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | - | 52wk Range: | - | 1-Yr Rtn: | - |
Key Statistics for STI
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. AS51 | - |
| Earnings Per Share (ttm) | -0.0180 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M AUD) | 0.00 |
| Shares Outstanding (M) | 2,225.11 |
| 30 Day Average Volume | - |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | - |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for STI
No data available
Company Profile & Key Executives for STI
Stirling Products Limited develops, commercializes and holds the rights to an animal growth promoting agent which is used for accelerating chemical changes in fat and muscles in livestock production.
| Peter BoonenChairman/Managing Director | Neil CoveyDirector:Sales & Marketing |
| John DiasinosSecretary | John BottenAdvisor/Consultant |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
STI News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page